Eli Lilly & Co. (LLY)
883.96
-33.69
(-3.67%)
USD |
NYSE |
Apr 24, 16:00
884.00
+0.04
(+0.00%)
Pre-Market: 20:00
Eli Lilly Market Cap : 789.69B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 79.46B |
| Viking Therapeutics, Inc. | 3.784B |
| Apellis Pharmaceuticals, Inc. | 5.233B |
| Arcellx, Inc. | 6.727B |
| Moderna, Inc. | 20.12B |
Market Cap Related Metrics
| PE Ratio | 39.13 |
| PS Ratio | 12.36 |
| PEG Ratio | 0.405 |
| Price to Book Value | 29.76 |
| Price to Free Cash Flow | 135.02 |
| Price | 883.96 |
| Earnings Yield | 2.56% |
| PEGY Ratio | 0.4021 |
| Operating PE Ratio | 27.12 |
| Normalized PE Ratio | 35.63 |